List of works - Stephanie Geisler

ABCB1 and GST polymorphisms associated with TP53 status in breast cancer

article published in 2007

Absence of p21 expression is associated with abnormal p53 in human breast carcinomas

scientific article

Alternative splicing and mutation status of CHEK2 in stage III breast cancer

scientific article

Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension

scientific article (publication date: 2012)

Concomitant inactivation of the p53- and pRB- functional pathways predicts resistance to DNA damaging drugs in breast cancer in vivo

scientific article

DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response

scientific article

Differential effect of carbamazepine and valproate monotherapy on plasma levels of oestrone sulphate and dehydroepiandrosterone sulphate in male epileptic patients

scientific article published on 01 May 1997

Effects of treatment with megestrol acetate on the insulin-like growth factor system: time and dose dependency

scientific article published on 01 July 1999

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

scientific article (publication date: 11 September 2001)

Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancer

article

Glomeruloid microvascular proliferation is associated with lack of response to chemotherapy in breast cancer

scientific article

Identification and characterization of retinoblastoma gene mutations disturbing apoptosis in human breast cancers

scientific article

Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer

scientific article published in March 2001

Plasma insulin-like growth factor binding protein-3 proteolysis is increased in primary breast cancer

scientific article published on July 2001

Predictive value of tumour cell proliferation in locally advanced breast cancer treated with neoadjuvant chemotherapy

scientific article published in March 2003

Primary systemic treatment with weekly doxorubicin monotherapy in women with locally advanced breast cancer; clinical experience and parameters predicting outcome

scientific article published on 01 January 1996

Prognostic and predictive value of changes in tumour cell proliferation in locally advanced breast cancer primarily treated with doxorubicin.

scientific article published in March 2005

Repeated observation of breast tumor subtypes in independent gene expression data sets

scientific article (publication date: 8 July 2003)

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

scientific article published on 01 July 1996

TP53 gene mutations predict the response to neoadjuvant treatment with 5-fluorouracil and mitomycin in locally advanced breast cancer

scientific article

List of works by Stephanie Geisler

ABCB1 and GST polymorphisms associated with TP53 status in breast cancer

Absence of p21 expression is associated with abnormal p53 in human breast carcinomas

Alternative splicing and mutation status of CHEK2 in stage III breast cancer

Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension

Concomitant inactivation of the p53- and pRB- functional pathways predicts resistance to DNA damaging drugs in breast cancer in vivo

DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response

Differential effect of carbamazepine and valproate monotherapy on plasma levels of oestrone sulphate and dehydroepiandrosterone sulphate in male epileptic patients

Effects of treatment with megestrol acetate on the insulin-like growth factor system: time and dose dependency

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancer

Glomeruloid microvascular proliferation is associated with lack of response to chemotherapy in breast cancer

Identification and characterization of retinoblastoma gene mutations disturbing apoptosis in human breast cancers

Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer

Plasma insulin-like growth factor binding protein-3 proteolysis is increased in primary breast cancer

Predictive value of tumour cell proliferation in locally advanced breast cancer treated with neoadjuvant chemotherapy

Primary systemic treatment with weekly doxorubicin monotherapy in women with locally advanced breast cancer; clinical experience and parameters predicting outcome

Prognostic and predictive value of changes in tumour cell proliferation in locally advanced breast cancer primarily treated with doxorubicin.

Repeated observation of breast tumor subtypes in independent gene expression data sets

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

TP53 gene mutations predict the response to neoadjuvant treatment with 5-fluorouracil and mitomycin in locally advanced breast cancer